Equities

Market movers

Constituents of the FTSE 350 with the highest percent gain over one day.
ListingLastChangeVolume
Wizz Air Holdings PLCWIZZ:LSE1,194.00
GBX
+82.00
+7.37%
1.37m
Burberry Group PLCBRBY:LSE1,272.50
GBX
+54.50
+4.47%
1.71m
Foresight Environmental Infrastructure LimitedFGEN:LSE67.40
GBX
+2.50
+3.85%
1.76m
Hays PLCHAS:LSE53.80
GBX
+1.75
+3.36%
2.27m
Harbour Energy PLCHBR:LSE205.80
GBX
+6.60
+3.31%
4.22m
Chemring Group PLCCHG:LSE475.00
GBX
+14.00
+3.04%
967.58k
Senior PLCSNR:LSE190.00
GBX
+5.60
+3.04%
798.83k
Goodwin PLCGDWN:LSE20,600.00
GBX
+600.00
+3.00%
5.09k
Hochschild Mining PLCHOC:LSE456.40
GBX
+12.20
+2.75%
6.24m
Morgan Advanced Materials PLCMGAM:LSE212.00
GBX
+5.50
+2.66%
551.61k
Data delayed at least 15 minutes, as of Dec 12 2025 16:10 GMT.

Mergers and acquisitions

Mergers and acquisitions across all companies with an updated deal status over the last 90 days

CompaniesDeal statusDeal valueDate
Netflix Inc acquired Warner Bros Discovery IncAnnounced69.92bn USD05 Dec 2025
Kimberly-Clark Corp acquired Kenvue IncAnnounced42.79bn USD03 Nov 2025
Abbott Laboratories acquired Exact Sciences CorpAnnounced22.57bn USD20 Nov 2025
International Business Machines Corp acquired Confluent IncAnnounced12.44bn USD08 Dec 2025
American Water Works Co Inc acquired Essential Utilities IncAnnounced12.26bn USD27 Oct 2025
114 total results

Institutional Ownership

Company% of available shares heldNet share increase since last reportedValue of change
First Trust Nasdaq Semiconductor ETFFTXL:NMQ:USD59.29%+11,487.59%762.56m USD
B&M European Value Retail SABMRRY:PNK0.07%+1,790.52%1.60m USD
Thor Medical ASATRMED:OSL1.13%+1,547.09%13.33m NOK
Kyverna Therapeutics IncKYTX:NSQ6.99%+1,377.09%23.46m USD
Vow ASAVOW:OSL1.46%+639.78%6.53m NOK
SIG Group AGSIGCY:PKL0.00%-1.00%-359.97k USD
Chart Industries IncGTLS PR B:NYQ0.00%-1.00%-122.34k USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.